Kimball Electronics, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Kimball Electronics, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	931	1,072	1,182	1,201	1,292	1,350	1,823	1,715	1,487	1,431
Cost of revenue	855	986	1,093	1,117	1,174	1,245	1,667	1,574	1,382	1,314
Gross profit	75.4	86	88.4	83.8	118	105	156	140	104	117
Research and development	10	11	15	16.9	20.9	23.7	24.4	18.3	17.5	19.1
Selling, general and administrative	36.7	44	46.7	43.9	52.7	53.4	68.6	66.6	50.3	61.2
Operating income	42.8	42	42.1	32	65.7	52.5	87.7	49.3	45.5	66.1
Interest expense	0.27	0.53	4.07	4.42	2.17	2.66	16.3	22.8	14.7	8.5
Interest income	0.06	0.07	0.06	0.06	0.1	0.08	0.15	0.64	0.77	1.23
Other non-operating income					6.41	-6.24	3.13	-1.88	-5.33	-5.56
Pre-tax income	44.3	44.8	38.5	25.2	70.1	43.7	74.7	25.2	26.2	53.2
Income tax	10.1	28	6.93	6.96	13.3	12.5	18.9	4.69	9.25	25.3
Net income	34.2	16.8	31.6	18.2	56.8	31.3	55.8	20.5	17	28
EBITDA	66.7	68.4	70.9	62.9	99.7	82	120	87.3	82.5	105
EPS, basic	1.25	0.63	1.22	0.72	2.26	1.24	2.24	0.82	0.68	1.14
EPS, diluted	1.24	0.62	1.21	0.71	2.24	1.24	2.22	0.81	0.68	1.13
Shares, basic (weighted)	27.4	26.7	25.9	25.2	25.1	25.1	24.9	25.1	24.8	24.5
Shares, diluted (weighted)	27.5	27	26.1	25.4	25.3	25.2	25.1	25.3	25	24.8

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	44.6	46.4	49.3	65	106	49.9	43	78	88.8	88.9
Receivables	170	174	226	180	203	223	308	282	223	219
Inventory	145	202	204	219	200	396	450	338	274	272
Other current assets	29.2	15.4	24.7	23.9	27.3	28.7	49.2	44.7	36	42.8
Total current assets	388	437	555	558	583	761	929	847	700	693
Property, plant and equipment	138	137	144	155	163	207	268	270	265	274
Lease right-of-use assets				2	1.6	3.1	2.6	1.77	11.8	10.9
Goodwill	6.19	6.19	18.1	12	12	12	12	6.19	6.19	6.19
Intangible assets	4.58	4.38	22.2	19.3	17	14.7	12.3	2.99	2.43	1.92
Other non-current assets	18.5	24	24.9	30.5	38.4	41.1	38.3	82.1	104	117
Total assets	555	609	764	775	814	1,036	1,260	1,208	1,077	1,092
Accounts payable	155	188	197	204	217	300	322	214	219	234
Accrued liabilities	34.6	32.4	43.2	42.3	58	47	72.5	63.2	46.5	58.9
Short-term debt								59.8	17.4	8.2
Total current liabilities	199	229	275	273	301	409	475	375	319	332
Long-term debt								235	130	108
Lease liabilities				1.21				1.14	11.4	14.5
Other non-current liabilities	13.4	12.3	18.1	21.6	22.5	20.2	19.7	53.9	59.2	66.8
Total liabilities	213	253	394	395	372	582	736	667	507	507
Total debt								295	147	116
Paid-in capital	302	304	306	307	308	311	315	319	323	326
Retained earnings	82.7	99.4	134	152	209	240	296	317	334	362
Treasury stock	-33.8	-41.2	-62.4	-69.1	-70.2	-77.7	-76.5	-77.8	-88	-97.5
Other comprehensive income	-9.08	-6.9	-7.63	-10.6	-4.88	-19.7	-11	-17.8	1.06	-4.67
Shareholders' equity	342	356	370	379	442	454	524	540	570	585
Total equity	342	356	370	379	442	454	524	540	570	585
Total liabilities and equity	555	609	764	775	814	1,036	1,260	1,208	1,077	1,092
Shares outstanding						24.6	24.7	24.7	24.2	24

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	34.2	16.8	31.6	18.2	56.8	31.3	55.8	20.5	17	28
Depreciation and amortization	23.9	26.4	28.9	30.9	34	29.4	32.4	38	37	38.7
Stock-based compensation	3.48	5.3	5.68	4.04	3.91	6.22	6.91	7.19	6.52	8.23
Deferred income tax	-0.88	2.45	-1.69	0.18	-6.09	1.04	-0.15	-10.3	0.87	0.71
Change in inventory	-8.55	-55.8	-35.1	-15.1	18.6	-203	-50.2	64.2	74.6	-19.9
Change in payables	9.49	33.3	8	3.62	14.5	89.2	20.4	-103	-2.79	20
Cash from operations	46.8	40.2	-6.75	72.8	130	-83.2	-13.8	73.2	184	72.3
Capital expenditures	-33.3	-25.9	-24.7	-38.4	-38.4	-74	-89.4	-46.1	-33.3	-51.5
Acquisitions	-2.14	0	-43.9	0	0
Cash from investing	-35.7	-26.2	-68.7	-38.5	-38.8	-74.8	-90.5	-46.5	-14.7	-25.9
Share buybacks	-22.3	-9.55	-23.4	-8.79	-3	-8.95	0	-2.85	-12	-11.9
Cash from financing	-22	-12.6	79.4	-17.9	-53.1	104	99.2	8.97	-161	-47.1
Exchange rate effect	0.81	0.49	-1.13	-0.68	3.23
Net change in cash	-10.2	1.87	2.85	15.7	41.5	-56.6	-5.99	34.9	10.7	0.17
Free cash flow	13.5	14.3	-31.4	34.4	91.7	-157	-103	27.1	151	20.8
Interest paid	0.3	0.4	3	4.93	2.53	2.33	15.3	19.4	18.1	9.04
Income taxes paid	5.9	14.7	10.2	9.1	13.4	14.3	13.7	27.3	12.8	14.2

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $19.45 on November 10, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	8.2%	Gross profit / revenue.
Operating margin	4.4%	Operating income / revenue.
EBITDA margin	7.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	3.4%	Pre-tax income / revenue.
Net margin	1.4%	Net income / revenue.
FCF margin	-0.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	3.1%	Cash from operations / revenue.
Effective tax rate	59.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	3.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.7%	Net income / average total assets.
Return on invested capital (ROIC)	6.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	4.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.4%	Capital expenditures / revenue.
D&A / revenue	2.8%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-3.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-7.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	2.1%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	12.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-9.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-0.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	45.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-9.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	0.1%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	26.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-4.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	1.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	64.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-20.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-13.2%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	66.2%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-20.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-12.8%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-60.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	-11.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-86.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-25.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	2.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	3.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	5.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-4.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.90x	Current assets / current liabilities.
Quick ratio	0.78x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.18x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.40x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	19.0%	Total debt / total assets.
Liabilities / assets	52.9%	Total liabilities / total assets.
Net debt	$162.6M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.55x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	6.62x	Operating income / interest expense.
Working capital	$357.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	6.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	$506.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.18x	Revenue / average total assets.
Fixed asset turnover	4.78x	Revenue / average property, plant and equipment.
Inventory turnover	4.28x	Cost of revenue / average inventory.
Days inventory	85 days	365 x average inventory / cost of revenue.
Receivables turnover	6.17x	Revenue / average receivables.
Days sales outstanding	59 days	365 x average receivables / revenue.
Days payables	71 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	73 days	Days inventory + days sales outstanding - days payables.
FCF conversion	-24.8%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	111.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.83	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$59.26	Revenue / diluted weighted shares.
FCF per share	-$0.21	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.83	Cash from operations / diluted weighted shares.
Book value per share	$24.28	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$21.12	Tangible book value / shares outstanding.
Cash per share	$3.03	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$467.8M	Share price x shares outstanding.
Enterprise value	$630.4M	Market cap + total debt - cash - short-term investments.
P/E	22.8x	Market cap / net income. Only when net income is positive.
P/S	0.32x	Market cap / revenue.
P/B	0.80x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.92x	Market cap / tangible book value, when positive.
P/OCF	10.4x	Market cap / cash from operations, when positive.
EV/Sales	0.43x	Enterprise value / revenue.
EV/EBIT	9.85x	Enterprise value / operating income, when both are positive.
EV/EBITDA	6.02x	Enterprise value / EBITDA, when both are positive.
FCF yield	-1.1%	Free cash flow / market cap.
Earnings yield	4.4%	Net income / market cap (the inverse of P/E).
Shareholder yield	2.9%	(Dividends paid + share buybacks) / market cap.

What was Kimball Electronics, Inc.'s revenue in fiscal 2026?

Kimball Electronics, Inc. reported revenue of $1.43B for fiscal 2026, 3.7% lower than the year before.

Was Kimball Electronics, Inc. profitable in fiscal 2026?

Yes. Net income was $28.0M, a net margin of 2%.

How much free cash flow did Kimball Electronics, Inc. generate in fiscal 2026?

Cash from operations of $72.3M minus capital expenditures of $51.5M left free cash flow of $20.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Kimball Electronics, Inc.